Published in Biofabrication on September 01, 2009
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat Biotechnol (2016) 2.20
3D bioprinting for engineering complex tissues. Biotechnol Adv (2015) 0.97
Development of functionalized multi-walled carbon-nanotube-based alginate hydrogels for enabling biomimetic technologies. Sci Rep (2016) 0.77
3D Bioprinting for Vascularized Tissue Fabrication. Ann Biomed Eng (2016) 0.77
Recent Advances in Bioink Design for 3D Bioprinting of Tissues and Organs. Front Bioeng Biotechnol (2017) 0.75
HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A (1998) 8.22
Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials (1999) 4.69
Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res (2002) 3.10
Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol (2004) 2.84
Endothelial, cardiac muscle and skeletal muscle exhibit different viscous and elastic properties as determined by atomic force microscopy. J Biomech (2001) 2.64
Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res (2002) 2.59
Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation (2000) 2.25
Cell sheet engineering for myocardial tissue reconstruction. Biomaterials (2003) 2.23
Inkjet printing for high-throughput cell patterning. Biomaterials (2004) 2.06
Inkjet printing of viable mammalian cells. Biomaterials (2005) 2.04
Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res (2002) 2.04
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90
Viability and electrophysiology of neural cell structures generated by the inkjet printing method. Biomaterials (2006) 1.42
Injection molding of chondrocyte/alginate constructs in the shape of facial implants. J Biomed Mater Res (2001) 1.42
Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation (1997) 1.38
Engineered heart tissue for regeneration of diseased hearts. Biomaterials (2004) 1.36
Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg (2001) 1.32
Novel alginate sponges for cell culture and transplantation. Biomaterials (1997) 1.15
Cell and organ printing 1: protein and cell printers. Anat Rec A Discov Mol Cell Evol Biol (2003) 1.13
Adult stem cell therapy for the heart. Int J Biochem Cell Biol (2004) 1.05
Construction of high-density bacterial colony arrays and patterns by the ink-jet method. Biotechnol Bioeng (2004) 0.97
Autologous heart cell transplantation improves cardiac function after myocardial injury. Ann Thorac Surg (1999) 0.97
In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg (2002) 0.94
Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol (1999) 0.92
Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors. Heart Fail Rev (2003) 0.89
Advances in tissue engineering: cell printing. J Thorac Cardiovasc Surg (2005) 0.84
Minimally invasive tissue engineering composites and cell printing. IEEE Eng Med Biol Mag (2003) 0.84
Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads as an extracorporeal bioartificial liver. Cell Transplant (1994) 0.82
Gel stretch method: a new method to measure constitutive properties of cardiac muscle cells. Am J Physiol (1998) 0.80
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet (2012) 3.66
Organ printing: computer-aided jet-based 3D tissue engineering. Trends Biotechnol (2003) 2.66
Inkjet printing of viable mammalian cells. Biomaterials (2005) 2.04
A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail (2003) 1.60
Human microvasculature fabrication using thermal inkjet printing technology. Biomaterials (2009) 1.55
Viability and electrophysiology of neural cell structures generated by the inkjet printing method. Biomaterials (2006) 1.42
Thermal inkjet printing in tissue engineering and regenerative medicine. Recent Pat Drug Deliv Formul (2012) 1.26
Cell damage evaluation of thermal inkjet printed Chinese hamster ovary cells. Biotechnol Bioeng (2010) 1.18
Rapid prototyping of tissue-engineering constructs, using photopolymerizable hydrogels and stereolithography. Tissue Eng (2004) 1.15
Cell and organ printing 1: protein and cell printers. Anat Rec A Discov Mol Cell Evol Biol (2003) 1.13
Electrophysiological characterization of embryonic hippocampal neurons cultured in a 3D collagen hydrogel. Biomaterials (2009) 1.06
Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am J Med (2013) 1.03
Construction of high-density bacterial colony arrays and patterns by the ink-jet method. Biotechnol Bioeng (2004) 0.97
Frictional properties of poly(MPC-co-BMA) phospholipid polymer for catheter applications. Biomaterials (2003) 0.96
Biofabrication: reappraising the definition of an evolving field. Biofabrication (2016) 0.94
Chronic ambulatory intracardiac pressures and future heart failure events. Circ Heart Fail (2010) 0.90
Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial. J Card Fail (2009) 0.89
The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail (2005) 0.88
Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling. Circ Heart Fail (2012) 0.86
Advances in tissue engineering: cell printing. J Thorac Cardiovasc Surg (2005) 0.84
Minimally invasive tissue engineering composites and cell printing. IEEE Eng Med Biol Mag (2003) 0.84
Synthesis and characterization of biodegradable elastomeric polyurethane scaffolds fabricated by the inkjet technique. Biomaterials (2008) 0.84
A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction. Eur J Heart Fail (2014) 0.84
The role of independently variable grafting density and layer thickness of polymer nanolayers on peptide adsorption and cell adhesion. Biomaterials (2006) 0.84
Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial. Congest Heart Fail (2011) 0.82
Loading dependent swelling and release properties of novel biodegradable, elastic and environmental stimuli-sensitive polyurethanes. J Control Release (2008) 0.82
Left ventricular diastolic function and exercise capacity in community-dwelling adults ≥65 years of age without heart failure. Am J Cardiol (2011) 0.80
Design and implementation of a two-dimensional inkjet bioprinter. Conf Proc IEEE Eng Med Biol Soc (2009) 0.80
In vitro evaluation of phosphonylated low-density polyethylene for vascular applications. J Biomed Mater Res (2002) 0.80
Experimental and numerical modeling of variable friction between nanoregions in coventional and crosslinked UHMWPE. J Biomech Eng (2004) 0.78
In vivo assessment of printed microvasculature in a bilayer skin graft to treat full-thickness wounds. Tissue Eng Part A (2014) 0.77
Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium. Histochem Cell Biol (2010) 0.77
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertension. Am Heart J (2006) 0.77
Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis. JAMA Ophthalmol (2013) 0.76
A quantitative approach to studying structures and orientation at self-assembled monolayer/fluid interfaces. J Colloid Interface Sci (2003) 0.75